Clinical Studies & Research
Aesthetic Solutions is an active research center, partnering with pharmaceutical and medical device manufacturers to bring the latest treatments to our patients and advance safe, effective aesthetic treatments.
Glabellar Neuromodulator 2406-103
Status: In Progress
Description:
This trial is evaluating the safety and effectiveness of a new type of neuromodulator to treat moderate to severe glabellar lines compared to a placebo.
Nasolabial Folds Filler 2404-101
Status: In Progress
Description:
Dr. Cox is serving as Principal Investigator on this clinical trial evaluating a new dermal filler for use in the nasolabial folds.
Jawline Filler 2309-99
Status: In Progress
Description:
Enrollment for this study has been completed. Dr. Cox is serving as Principal Investigator. This is a randomized, blinded evaluator, No-Treatment control, multicenter, prospective clinical study, to identify whether a currently FDA approved filler is superior to No-Treatment for the correction of moderate to severe sagging jawline.
Temple Filler 2303-97
Status: In Progress
Description:
This study will evaluate the safety and effectiveness of an FDA approved filler to the temple area. Dr. Cox will be serving as principal investigator.
Transverse Neck Lines 2204-80
Status: In Progress
Description:
We have completed enrollment for this study evaluating the safety and efficacy of an injectable for the improvement of neck appearance. Dr. Cox will be serving as principal investigator.
Midface Filler 2206-78
Status: In Progress
Description:
This study will be comparing a new filler to an existing FDA approved filler for midface augmentation. Dr. Cox is serving as principal investigator.
Skin Laxity Scale 2308-100
Status: Completed
Description: Dr. Cox is completed work to develop a patient-reported outcome skin laxity scale. This began in August 2023 and ended in 2024.
Belly Fat 2305-98
Status: Completed
Description: Dr. Cox completed work as Principal Investigator for this study evaluating the efficacy, safety, and tolerability of a new injectable product to reduce belly fat. Dr. Cox found mixed results with this product. We hope to see more innovations in this exciting new area of noninvasive fat reduction. This study began in May 2023 and completed in December 2024.
Photonumeric Scale 2207-96
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for Abdominal Fat. This was completed in July of 2022.
Photonumeric Scale 2202-93
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for the Forehead. This was completed in February of 2022.
Photonumeric Scale 2202-92
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for the Crow's Feet. This was completed in February of 2022.
Photonumeric Scale 2109-91
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for Temple Volume Deficit. This was completed in September of 2022.
Photonumeric Scale 2109-90
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for Chin Retrusion. This was completed in September of 2022.
Photonumeric Scale 2201-88
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale. This was completed in 2022.
Jawline Filler 2208-95
Status: Completed
Description: Dr. Cox completed work as Principal Investigator for this study evaluating the effectiveness and safety of a new injectable filler (Galderma GP109) for jawline definition. This study began in August 2022 and ended in November 2024. We hope to see this product on the market in the future!
Photonumeric Scale 2109-89
Status: Completed
Description: Dr. Cox served as an Independent Reviewer for the Development & Validation of a Photonumeric Scale for the Jawline. This was completed in September of 2022.